Peeling Back The Layers: Exploring ANI Pharmaceuticals Through Analyst Insights
Peeling Back The Layers: Exploring ANI Pharmaceuticals Through Analyst Insights
揭開層層面紗：通過分析師洞察探索ani pharmaceuticals
A clear picture of ANI Pharmaceuticals's perception among financial...ANI Pharmaceuticals (NASDAQ:ANIP) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
ani pharmaceuticals（納斯達克：ANIP）在過去三個月內接受了5位分析師的分析，他們的觀點從看好到看淡不一。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
總結他們最近的評估，下表展示了過去30天內不斷變化的情緒，並將其與之前的幾個月進行了比較。
Analysts have set 12-month price targets for ANI Pharmaceuticals, revealing an average target of $79.8, a high estimate of $94.00, and a low estimate of $60.00. Highlighting a 8.54% decrease, the current average has fallen from the previous average price target of $87.25.
分析師爲ani製藥公司設定了12個月的目標股價，平均目標爲79.8美元，最高估值爲94.00美元，最低估值爲60.00美元。當前平均目標價下降了8.54%，從先前的87.25美元的平均目標價降至目前水平。
Investigating Analyst Ratings: An Elaborate Study
分析師評級的調查：一項詳盡的研究
A clear picture of ANI Pharmaceuticals's perception among financial...
通過對最近分析師的行...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間